Santrax SB 500mg/250mg Injection
Marketer
Ultratech Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Santrax SB 500mg/250mg Injection
Combiflox 500mg/250mg injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and hydration are recommended for optimal recovery. Your doctor might order laboratory and imaging tests to monitor therapeutic response.
Uses of Santrax SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Santrax SB 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Santrax SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Santrax SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Santrax SB 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Santrax SB 500mg/250mg Injection, offer a powerful antibacterial approach. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of alcohol and Santrax SB 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Santrax SB, 500mg/250mg, is typically deemed safe for use in pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Santrax SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Santrax SB 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Operation of a motor vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Santrax SB 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500mg/250mg Santrax SB Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Santrax SB 500mg/250mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Santrax SB 500mg/250mg Injection :
Omit a scheduled Santrax SB 500mg/250mg Injection? Seek immediate medical advice.
Facts to Know About Santrax SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently